-0.075 (-0.129%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Corcept Therapeutics Incorporated.
Telephone
1.650.327.3270
Address
101 Redwood Shores Parkway, Redwood City, CA 94065
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 28.67 - 91
Trade Value (12mth)
US$20,095.00
1 week
2.09%
1 month
28.41%
YTD
57.54%
1 year
-22.66%
All time high
115.27
EPS 3 yr Growth
-0.30%
EBITDA Margin
6.10%
Operating Cashflow
$142m
Free Cash Flow Return
21.20%
ROIC
14.70%
Interest Coverage
0.00
Quick Ratio
2.80
Shares Outstanding (Fully Diluted)
104m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
Historical data
Forecast data
| 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | GBP |  | | | | 1.02 | 1.35 | 0.95 | | | | ||
EPS (Fully Diluted) | GBP | | | | | 0.94 | 1.23 | 0.82 | | | | ||
Growth | % | | | | | 7.4 | 32.9 | -30.2 | | | | ||
PE | X | | | | | 34.4 | 40.9 | 42.5 | | | | ||
EV/EBITDA | X | | | | | 30.1 | 38.6 | 81.5 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
